About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes & Endocrinology

by Himabindu Venkatakrishnan on April 28, 2014 at 11:50 AM
Font : A-A+

 Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes & Endocrinology

Insufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, is available with physicians, suggests a Comment in The Lancet Diabetes & Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.

While the benefits of testosterone therapy in younger men with a deficiency of the hormone are well established, testosterone is now widely prescribed to older men, particularly in the USA.

Advertisement

Existing studies have produced conflicting findings over whether the prescription of testosterone is associated with increased cardiovascular risk in older men, and ongoing studies are unlikely to adequately address this question, meaning that even if an appropriately powered trial were to start today, reliable safety data are at least a decade away.

According to Professor Page, "In an era when millions of men are using testosterone every day, support is urgently needed from both the public and medical communities to fund an appropriate clinical study to assess the risks and benefits of testosterone treatment in older men. There is a danger that funding and regulatory agencies will overinterpret the evidence from existing and ongoing observational studies, and conclude that larger and longer clinical trials are unnecessary and unwarranted. This conclusion would do men's health a disservice."*
Advertisement

"Testosterone is a billion dollar industry, probably fuelled partly by direct to consumer advertising and some degree of overprescription," Professor Page adds. "Physicians need to discuss with their patients that we simply do not fully understand the risks associated with testosterone use in older men, and use conservative treatment guidelines - such as those provided by the Endocrine Society - to guide therapeutic decisions."*

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Diabetes Diabetic Diet Clinical Trials Diabetes - Essentials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise 

Most Popular on Medindia

The Essence of Yoga Color Blindness Calculator Blood Donation - Recipients Loram (2 mg) (Lorazepam) Drug Side Effects Calculator Selfie Addiction Calculator Blood - Sugar Chart A-Z Drug Brands in India Sanatogen Find a Doctor
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Urgent Requirement of Large Clinical Trials to Evaluate Risks of Testosterone Treatment: Lancet Diabetes & Endocrinology Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests